Literature DB >> 26152801

The association between clinically relevant anxiety and other non-motor symptoms in Parkinson's disease.

Si-Ming Jiang1, Yong-Sheng Yuan1, Qing Tong1, Li Zhang1, Qin-Rong Xu1, Jian Ding1, Ke-Zhong Zhang2.   

Abstract

Anxiety disorders in patients with Parkinson's disease (PD) are often missed due to an overlap with other non-motor symptoms. The relationships between anxiety and other non-motor symptoms in PD still remain unclear. We used the Hamilton anxiety rating scale and the Non-motor Symptoms Questionnaire to measure anxiety and the complex range of non-motor symptoms in 99 PD patients. The relationships between anxiety and other PD-related non-motor symptoms were examined through regression analyses. 25 % of PD patients were diagnosed with clinically relevant anxiety. Non-motor symptoms were more prominent in patients with anxiety. Depression, urinary disorders, and sleep disruption were the factors most likely to influence anxiety in PD. Our findings have revealed a strong interplay between anxiety and other non-motor symptoms of PD and have highlighted the need for a holistic approach towards the clinical treatment of this disabling condition.

Entities:  

Keywords:  Anxiety; Hamilton anxiety rating scale; Non-motor symptoms; Parkinson’s disease

Mesh:

Substances:

Year:  2015        PMID: 26152801     DOI: 10.1007/s10072-015-2320-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

1.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.

Authors:  Gregory M Pontone; James R Williams; Karen E Anderson; Gary Chase; Susanne A Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Peter V Rabins; Howard D Weiss; Laura Marsh
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

2.  Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study.

Authors:  Albert F G Leentjens; Kathy Dujardin; Laura Marsh; Pablo Martinez-Martin; Irene H Richard; Sergio E Starkstein
Journal:  Mov Disord       Date:  2011-02-10       Impact factor: 10.338

3.  When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease?

Authors:  Silvio R De Luka; Marina Svetel; Tatjana Pekmezović; Branislav Milovanović; Vladimir S Kostić
Journal:  Vojnosanit Pregl       Date:  2014-04       Impact factor: 0.168

4.  Force overflow and levodopa-induced dyskinesias in Parkinson's disease.

Authors:  Roland Wenzelburger; Bao-Rong Zhang; Sabine Pohle; Stephan Klebe; Delia Lorenz; Jan Herzog; Henrik Wilms; Günther Deuschl; Paul Krack
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

5.  Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

Authors:  L M Shulman; R L Taback; A A Rabinstein; W J Weiner
Journal:  Parkinsonism Relat Disord       Date:  2002-01       Impact factor: 4.891

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Anxiety in Parkinson's disease: Symptom dimensions and overlap with depression and autonomic failure.

Authors:  Sonja Rutten; Ires Ghielen; Chris Vriend; Adriaan W Hoogendoorn; Henk W Berendse; Albert F G Leentjens; Ysbrand D van der Werf; Jan H Smit; Odile A van den Heuvel
Journal:  Parkinsonism Relat Disord       Date:  2014-12-10       Impact factor: 4.891

9.  Autonomic failure, depression and anxiety in Parkinson's disease.

Authors:  G E Berrios; C Campbell; B E Politynska
Journal:  Br J Psychiatry       Date:  1995-06       Impact factor: 9.319

10.  "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.

Authors:  A Vázquez; F J Jiménez-Jiménez; P García-Ruiz; D García-Urra
Journal:  Acta Neurol Scand       Date:  1993-01       Impact factor: 3.209

View more
  5 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  Motion and emotion: anxiety-axial connections in Parkinson's disease.

Authors:  Rastislav Šumec; Irena Rektorová; Robert Jech; Kateřina Menšíková; Jan Roth; Evžen Růžička; Dana Sochorová; Ladislav Dušek; Petr Kaňovský; Ivan Rektor; Tomáš Pavlík; Pavel Filip; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2016-11-23       Impact factor: 3.575

3.  Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease.

Authors:  Shi-Shuang Cui; Juan-Juan Du; Rao Fu; Yi-Qi Lin; Pei Huang; Ya-Chao He; Chao Gao; Hua-Long Wang; Sheng-Di Chen
Journal:  BMC Geriatr       Date:  2017-11-22       Impact factor: 3.921

Review 4.  Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.

Authors:  Josiel Mileno Mack; Marissa Giovanna Schamne; Tuane Bazanella Sampaio; Renata Aparecida Nedel Pértile; Pedro Augusto Carlos Magno Fernandes; Regina P Markus; Rui Daniel Prediger
Journal:  Oxid Med Cell Longev       Date:  2016-10-18       Impact factor: 6.543

5.  Altered putamen functional connectivity is associated with anxiety disorder in Parkinson's disease.

Authors:  Xixi Wang; Junyi Li; Yongsheng Yuan; Min Wang; Jian Ding; Jiejin Zhang; Lin Zhu; Yuting Shen; Hui Zhang; Kezhong Zhang
Journal:  Oncotarget       Date:  2017-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.